Cumulative disease-free and overall survival of CRC patients with high or low CXCL14 expression. A and B, Kaplan-Meier disease-free survival curves to estimate survival of AJCC stage I/II CRC patients (A) and AJCC stage II CRC patients (B). C and D, Kaplan-Meier overall survival curves to estimate survival of AJCC stage III/IV CRC patients (C) and AJCC stage III CRC patients (D). Comparison was made of groups with high CXCL14 and low CXCL14 expression. Marks on graph lines represent censored samples. P value refers to two-sided log-rank tests.